Ignite Creation Date:
2025-12-25 @ 1:32 AM
Ignite Modification Date:
2025-12-25 @ 11:50 PM
Study NCT ID:
NCT03490994
Status:
UNKNOWN
Last Update Posted:
2019-01-10
First Post:
2018-03-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Rivaroxaban Once Daily Versus Dose-adjusted Vitamin K Antagonist on the Biomarkers in Acute Decompensated Heart Failure and Atrial Fibrillation (ROAD HF-AF)
Sponsor:
Yonsei University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-04-10
Start Date Type:
ACTUAL
Primary Completion Date:
2019-09
Primary Completion Date Type:
ESTIMATED
Completion Date:
2020-01
Completion Date Type:
ESTIMATED
First Submit Date:
2018-03-11
First Submit QC Date:
None
Study First Post Date:
2018-04-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-01-09
Last Update Post Date:
2019-01-10
Last Update Post Date Type:
ACTUAL